Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNAMMO-T2D
NCT02697201Phase 1Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jul 2016
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by Pennington Biomedical Research Center. Primary endpoint: Effects of lipid infusion on mitochondrial fission at 5 years. Started Jul 2016; status: completed.
Beyond the preview
Go deeper on NCT02697201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697201.